CAMBRIDGE, Mass.--(BUSINESS WIRE)--NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo pathology, today announced that the company has initiated a clinical trial to evaluate high-resolution optical imaging of Barretts esophagus using its proprietary Nvision VLE Imaging System, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA...

BRUSSELS, Feb. 22, 2012 /PRNewswire/ -- UCB today announced the start of C-EARLY a phase III study that will evaluate the efficacy and safety of Cimzia (certolizumab pegol) in combination with methotrexate (MTX) for inducing and sustaining clinical response in adults with early, progressive, active, moderate...

Increased Awareness Among Clinicians and Parents Could Lead to Earlier Diagnosis and Intervention for Minority Children with ASD

BALTIMORE, Feb. 21, 2012 /PRNewswire-USNewswire/ -- The first prospective study of ethnic differences in the symptoms of autism in toddlers shows...

NEW ORLEANS, Feb. 21, 2012 /PRNewswire-USNewswire/ -- New research finds foreign-born Hispanics now living in the United States appear to be less likely to have a stroke compared to non-Hispanic white people. The research was released today and will be presented at the

BLUE BELL, Pa., Feb. 22, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO) announced today that its next generation surface skin electroporation technology was successfully used to significantly enhance the delivery of small interfering RNA (siRNA) molecules to skin in animal studies. The data...

Hamburg and Munich, Germany, February 22, 2012 / B3C newswire / - apceth GmbH & Co. KG, located in Munich, Germany, and Indivumed GmbH, based in Hamburg, Germany, have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the treatment of solid cancers with cellular and / or gene therapeutics. The goal is to predict the response of a targeted cellular...

MONROVIA, Calif. and INGELHEIM, Germany, Feb. 21, 2012 /PRNewswire/ -- Xencor, Inc., a company using its proprietary Protein Design Automation (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for...

PLEASANTON, Calif., Feb. 22, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and Life Technologies Corporation (LTC) announced today that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications.

Under these two agreements, Roche has granted...

MERIDEN, Conn., Feb. 22, 2012 /PRNewswire/ -- Protein Sciences Corporation ("Protein Sciences") announced today that it has granted Merck, through a subsidiary, a non-exclusive license to Protein Sciences' proprietary expresSF serum-free insect cell line (SF) and related technology (collectively, PS Technology...

LEXINGTON, Massachusetts, February 22, 2012 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use has approved the production of VPRIV (velaglucerase...

CARSON CITY, Nev., Feb. 21, 2012 /PRNewswire/ -- OphthaliX(OTCBB: OPLI) announced that the Chinese State Intellectual Property Office (SIPO) issued a Certificate of Patent Invention for Chinese Patent Application No. 200680047569.7 entitled "Adenosine A3 receptor agonists for the treatment of dry eye disorders...

RALEIGH, N.C., Feb. 22, 2012 /PRNewswire/ -- The United States Patent & Trademark Office (USPTO) has informed BioDelivery Sciences International, Inc. (Nasdaq: BDSI) that it has rejected all claims by MonoSol Rx, LLC (MonoSol) in its US Patent No. 7,425,292 (the '292 Patent) which is currently being asserted...

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health plans to post for note holders its full-year 2011 financial results on Tuesday, February 28, 2012. The company will conduct a conference call for IMSs note holders to review these results at 11:00 a.m. ET on Friday, March 2, 2012. To obtain additional details for accessing the companys results and joining the conference call, note holders should e-mail...

NEWARK, N.J., Feb. 21, 2012 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB) (the "Company") today announced that on January 31, 2012, its board of directors adopted resolutions approving a reverse stock split (the "Reverse Split") of the outstanding...

PITTSBURGH, Feb. 21, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today hosted an investor meeting in New York, during which it provided its strategic vision for 2012 and beyond. As part of this, Mylan presented its financial guidance for 2012, reaffirmed its growth targets...

Fourth Quarter and Year End 2011 Financial Results

VANCOUVER, Feb. 21, 2012 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2011, on

Ludwigshafen, Germany/Florham Park, NJ - February 22, 2012 - BASF has opened a new white biotechnology and microbiology research center in Tarrytown, New York. In the laboratory, biologists and biotechnologists will work to develop more efficient biotechnological production processes and together with material researchers develop new antimicrobial products for medical technology...

Penzberg, Germany, February 22, 2012 -- TATAA Biocenter, Europes leading provider of genomic services using quantitative real-time polymerase PCR (qPCR), is expanding its offerings to high-throughput gene expression profiling using Roches RealTime ready Custom qPCR Assays and Panels. TATAA Biocenter's laboratories provide contract research for a full range of real-time qPCR services, including primer...

BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 22, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company focused on cardiovascular disease, announced today that it will host a conference call with members of Amarin senior management to discuss the company's fourth quarter and year-end 2011 financial results and 2012 business initiatives on Wednesday, February...

PEABODY, Mass., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG) announced today that it will conduct a conference call on Tuesday, March 6, 2012, at 5:00 p.m. (ET) to discuss results for the second quarter ended January 31, 2012. The conference call will include presentations by Jim Green, president and CEO, and Michael Levitz, senior vice president and chief financial officer...